OCUGEN, INC. Current Liabilities
OCUGEN, INC. (OCGN) had Current Liabilities of $133.08 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-06
- 2026-06-30: Liabilities, Current $133.08M.
- 2026-03-31: Liabilities, Current $20.71M.
- 2025-12-31: Liabilities, Current $23.04M.
- 2025-09-30: Liabilities, Current $20.36M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $133.08M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $20.71M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $23.04M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $20.36M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $17.99M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $16.89M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $21.59M 10-K · filed 2026-03-04 | |
| 2024-09-30 | $15.76M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $17.97M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $16.05M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $17.09M 10-K · filed 2025-03-05 | |
| 2023-09-30 | $19.73M 10-K · filed 2024-04-16 | $11.14M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $24.50M 10-K · filed 2024-04-16 | $13.46M 10-Q · filed 2023-08-21 |
| 2023-03-31 | $26.58M 10-K · filed 2024-04-16 | $15.68M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $28.53M 10-K · filed 2024-04-16 | $18.46M 10-K · filed 2023-02-28 |
| 2022-09-30 | $24.52M 10-K · filed 2024-04-16 | $14.91M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $17.96M 10-K · filed 2024-04-16 | $10.34M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $13.30M 10-K · filed 2024-04-16 | $7.69M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $7.00M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $6.23M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $4.84M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $4.28M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $3.61M 10-K · filed 2022-02-28 | $3.61M 10-K · filed 2021-03-19 |
| 2020-09-30 | $4.13M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $7.04M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $3.31M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $4.54M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $35.41M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $8.89M 8-K/A · filed 2019-10-07 | $791.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $2.32M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $14.11M 10-K · filed 2020-03-27 | $2.87M 10-K · filed 2019-03-22 |
| 2018-09-30 | $8.94M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $11.66M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $8.42M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $3.81M 10-K · filed 2019-03-22 | |
| 2017-09-30 | $2.91M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.83M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $3.90M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $5.17M 10-K · filed 2018-03-15 | |
| 2016-09-30 | $7.21M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $6.72M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $5.97M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $6.36M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $6.69M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $6.69M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $7.50M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $7.60M 10-K · filed 2016-03-10 | $8.25M 10-Q · filed 2015-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |